Generated by AI
Invesco Biotechnology & Genome ETF is an exchange-traded fund that targets U.S. biotechnology and genome companies, using the Dynamic Biotech & Genome Intellidex as its benchmark. The fund generally invests at least 90% of its assets in common stocks of companies included in the index, with holdings centered on businesses involved in biotechnology, genetic engineering, and related life-science research. Its portfolio is designed to give investors diversified exposure to a focused segment of the health care market through a rules-based selection process. Invesco Biotechnology & Genome ETF typically includes companies developing therapies, diagnostics, research tools, and genomic technologies, making it a specialized vehicle for participating in the biotechnology industry’s broader ecosystem. Managed by Invesco, it serves as a sector-focused ETF for investors seeking concentrated exposure to innovative health science companies rather than the broader equity market.
Summary of Jun 7's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about PBE also mention these. Each card shows that asset’s own numbers for the past 24 hours.